Abstract
Chemotherapy and radiation can both significantly decrease fertility potential. For chemotherapy, factors such as dose, age of patient, type of cancer, and type of drug being used are the most significant prognostic factors in determining future reproductive potential. As the dose and age of a patient increases, the chance of pregnancy decreases. Alkylating agents are the biggest culprits of decreased fertility. Some cancers that are more associated with decreased fertility potential are Hodgkin’s lymphoma and breast cancer. For radiotherapy, the most significant factors for future reproductive potential are dose and location. Radiotherapy to the ovaries is the most significant risk factor for acute ovarian failure. There is a direct inverse relationship between radiation dose and fertility potential. Considering the high cure rate of childhood cancers and the deleterious long-term effects of chemotherapy and radiation, it is important to be familiar with both the treatment options for cancer and future fertility.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Stovall D, McGee E. How chemotherapy harms ovarian function and how to assess your patients’ risk and reproductive status. Srm-ejournal.com. Accessed September 2, 2010.
Childhood cancers: National Cancer Institute. http://www.cancer.gov/cancertopics/factsheet/Sites-Types/childhood. Accessed September 2, 2010.
Larsen EC, Müller J, Schmiegelow K, Rechnitzer C, Andersen AN. Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab. 2003;88(11):5307–14.
Cohen L. Cancer treatment and the ovary: the effects of chemotherapy and radiation. Ann N Y Acad Sci. 2008;1135:123–5.
Salooja N, Reddy N, Apperley J. Vulnerability of the reproductive system to radiotherapy and chemotherapy. In: Tulandi T, Gosden R, editors. Preservation of fertility. London: Taylor & Francis; 2004. p. 39–64.
Johnston RJ, Wallace WH. Normal ovarian function and assessment of ovarian reserve in the survivor of childhood cancer. Pediatr Blood Cancer. 2009;53(2):296–302.
Tarlatzis BC, Zepiridis L. Perimenopausal conception. Ann N Y Acad Sci. 2003;997:93–104.
Byrne J, Fears TR, Gail MH, Pee D, Connelly RR, Austin DF, et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol. 1992;166(3):788–93.
Byrne J. Infertility and premature menopause in childhood cancer survivors. Med Pediatr Oncol. 1999;33(1):24–8.
Knopman JM, Papadopoulos EB, Grifo JA, Fino ME, Noyes N. Surviving childhood and reproductive-age malignancy: effects on fertility and future parenthood. Lancet Oncol. 2010;11(5):490–8.
Knauff EA, Marinus JC, Eijkemans MJ, et al. Anti-müllerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab. 2009;94(3):786–92.
Bath LE, Wallace WHB, Shaw MP, Fitzpatrick C, Anderson RA. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod. 2003;18(11):2368–74.
Muttukrishna S, McGarrigle H, Wakim R, Khadum I, Ranieri DM, Serhal P. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology. BJOG. 2005;112(10):1384–90.
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin. 2009;59(4):225–49.
Anderson RA, Themmen APN, Qahtani AA, Groome NP, Cameron DA. The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod. 2006;21(10):2583–92.
Meirow D, Dor J, Kaufman B, Shrim A, Rabinovici J, Schiff E, et al. Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod. 2007;22(6):1626–33.
Meirow D. Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hemato-oncological neoplasias and other cancers. Leuk Lymphoma. 1999;33(1–2):65–76.
Blumenfeld Z. Gynaecologic concerns for young women exposed to gonadotoxic chemotherapy. Curr Opin Obstet Gynecol. 2003;15(5):359–70.
Ben-Aharon I, Bar-Joseph H, Tzarfaty G, Kuchinsky L, Rizel S, Stemmer SM, et al. Doxorubicin-induced ovarian toxicity. Reprod Biol Endocrinol. 2010;8:20.
Chemaitilly W, Mertens AC, Mitby P, Whitton J, Stovall M, Yasui Y, et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab. 2006;91(5):1723–8.
Schwartz C. Long-term survivors of childhood cancer: the late effects of therapy. Oncologist. 1999;4(1): 45–54.
Green DM, Sklar CA, Boice Jr JD, Mulvihill JJ, Whitton JA, Stovall M, et al. Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27(14):2374–81.
Shamberger RC, Rosenberg SA, Seipp CA, et al. Effects of high-dose methotrexate and vincristine on ovarian and testicular functions in patients undergoing postoperative adjuvant treatment of ostosarcoma. Cancer Treat Rep. 1981;65:739–746.
Koyama H, Wada T, Nishizawa Y, et al. Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer. 1977;39:1403–1409.
Blumenfeld Z. Preservation of fertility and ovarian function and minimalization of chemotherapy associated gonadotoxicity and premature ovarian failure: the role of inhibin-A and -B as markers. Mol Cell Endocrinol. 2002;187(1–2):93–105.
Wallace WHB, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered. Lancet Oncol. 2005;6(4): 209–18.
Blumenfeld Z, Avivi I, Ritter M, Rowe JM. Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women. J Soc Gynecol Investig. 1999;6(5):229–39.
Kovacs P. Preserving ovarian function after breast cancer treatment. http://www.medscape.com/viewarticle/701901. Accessed September 2010.
Anchan RM, Ginsburg ES. Fertility concerns and preservation in younger women with breast cancer. Crit Rev Oncol Hematol. 2010;74(3):175–92.
Arya LS, Kotikanyadanam SP, Bhargava M, Saxena R, Sazawal S, Bakhshi S, et al. Pattern of relapse in childhood ALL: challenges and lessons from a uniform treatment protocol. J Pediatr Hematol Oncol. 2010;32(5):370–5.
Veitia RA, Gluckman E, Fellous M, Soulier J. Recovery of female fertility after chemotherapy, irradiation, and bone marrow allograft: further evidence against massive oocyte regeneration by bone marrow-derived germline stem cells. Stem Cells. 2007;25(5): 1334–5.
Sarafoglou K, Boulad F, Gillio A, Sklar C. Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr. 1997;130(2): 210–6.
Liu J, Malhotra R, Voltarelli J, Stracieri AB, Oliveira L, Simoes BP, et al. Ovarian recovery after stem cell transplantation. Bone Marrow Transplant. 2008;41(3): 275–8.
Wallace WH, Thomson AB, Saran F, et al. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005;62:738–44.
Thomas GM. Female genital tract. In: Cox J, Ang K, editors. Radiation oncology: rationale, technique, results. 8th ed. St. Louis, MO: Mosby; 2003. p. 758.
Ogilvy-Stuart AL, Shalet SM. Effect of radiation on the human reproductive system. Environ Health Perspect. 1993;101 Suppl 2:109–16.
Critchley HO, Bath LE, Wallace WH. Radiation damage to the uterus – review of the effects of treatment of childhood cancer. Hum Fertil (Camb). 2002;5(2):61–6.
Bath LE, Critchley HOD, Chambers SE, Anderson RA, Kelnar CJ, Wallace WH. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement. Br J Obstet Gynaecol. 1999;106(12):1265–72.
Faddy MJ, Gosden RG. A model conforming the decline in follicle numbers to the age of menopause in women. Hum Reprod. 1996;11(7):1484–6.
Wallace WHB, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005;62(3):738–44.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Kriseman, M.L., Kovanci, E. (2012). Impact of Chemotherapy and Radiotherapy on the Ovary. In: Seli, E., Agarwal, A. (eds) Fertility Preservation. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1783-6_4
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1783-6_4
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1782-9
Online ISBN: 978-1-4419-1783-6
eBook Packages: MedicineMedicine (R0)